Joint manifestations in FMF can be treated with IL-1 antagonists.
Massaro, M., Verrecchia, E., Sicignano, L. L., Murace, C. A., Rigante, D., Manna, R., LONG-TERM EFFICACY OF ANTI IL1 INHIBITION SEVERE JOINT INVOLVEMENT IN AN FMF PATIENT, <<CLINICAL AND EXPERIMENTAL RHEUMATOLOGY>>, 2025; 42 (10): 1-2 [https://hdl.handle.net/10807/320022]
LONG-TERM EFFICACY OF ANTI IL1 INHIBITION SEVERE JOINT INVOLVEMENT IN AN FMF PATIENT
Verrecchia, Elena;Sicignano, Ludovico Luca;Murace, Celeste Ambra;Rigante, Donato;Manna, Raffaele
2024
Abstract
Joint manifestations in FMF can be treated with IL-1 antagonists.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
